Qinghai Spring Medicinal Resources Technology Co Ltd (600381) — Tangible Net Worth Ratio
Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Tangible Net Worth Ratio of 94.0% as of March 2026. This metric is calculated by deducting intangible assets (CN¥58.96 Million) from net assets (CN¥983.66 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Qinghai Spring Medicinal Resources Techn (600381) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Qinghai Spring Medicinal Resources Technology Co Ltd Tangible Net Worth Ratio (1998–2025)
This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Tangible Net Worth Ratio has changed across 23 annual periods from 1998 to 2025. As of March 2026, the ratio stands at 94.0%, reflecting net assets of CN¥983.66 Million with intangible assets of CN¥58.96 Million CNY. See 600381 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025, covering 23 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 600381 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.1% | CN¥999.61 Million | CN¥59.30 Million | CN¥1.04 Billion | ▲ +1.2 pp |
| 2024 | 92.8% | CN¥1.04 Billion | CN¥74.29 Million | CN¥1.16 Billion | ▼ -0.6 pp |
| 2023 | 93.4% | CN¥1.27 Billion | CN¥83.25 Million | CN¥1.36 Billion | ▼ -1.0 pp |
| 2022 | 94.5% | CN¥1.53 Billion | CN¥84.68 Million | CN¥1.56 Billion | ▲ +2.5 pp |
| 2021 | 92.0% | CN¥1.82 Billion | CN¥145.78 Million | CN¥1.85 Billion | ▲ +0.0 pp |
| 2020 | 92.0% | CN¥2.07 Billion | CN¥166.36 Million | CN¥2.21 Billion | ▼ -3.4 pp |
| 2019 | 95.4% | CN¥2.39 Billion | CN¥109.99 Million | CN¥2.41 Billion | ▲ +1.2 pp |
| 2018 | 94.2% | CN¥2.38 Billion | CN¥137.53 Million | CN¥2.44 Billion | ▲ +1.5 pp |
| 2017 | 92.8% | CN¥2.32 Billion | CN¥167.71 Million | CN¥2.43 Billion | ▲ +2.7 pp |
| 2016 | 90.0% | CN¥2.00 Billion | CN¥199.60 Million | CN¥2.21 Billion | ▲ +3.0 pp |
| 2015 | 87.0% | CN¥1.76 Billion | CN¥228.27 Million | CN¥2.11 Billion | ▼ -12.9 pp |
| 2014 | 99.9% | CN¥308.44 Million | CN¥368.26K | CN¥1.44 Billion | ▲ +0.6 pp |
| 2013 | 99.3% | CN¥50.03 Million | CN¥374.13K | CN¥1.49 Billion | ▲ +21.2 pp |
| 2012 | 78.1% | CN¥2.15 Billion | CN¥472.31 Million | CN¥4.05 Billion | ▼ -2.5 pp |
| 2011 | 80.5% | CN¥2.32 Billion | CN¥450.94 Million | CN¥3.94 Billion | ▼ -19.4 pp |
| 2005 | 100.0% | CN¥327.77 Million | CN¥72.63K | CN¥1.37 Billion | ▲ +3.9 pp |
| 2004 | 96.1% | CN¥489.71 Million | CN¥19.17 Million | CN¥1.71 Billion | ▲ +2.8 pp |
| 2003 | 93.3% | CN¥391.64 Million | CN¥26.44 Million | CN¥1.18 Billion | ▲ +0.7 pp |
| 2002 | 92.6% | CN¥351.79 Million | CN¥26.06 Million | CN¥767.69 Million | ▼ -7.4 pp |
| 2001 | 100.0% | CN¥333.98 Million | CN¥0.00 | CN¥598.92 Million | ▲ +0.0 pp |
| 2000 | 100.0% | CN¥117.80 Million | CN¥0.00 | CN¥305.71 Million | ▲ +0.0 pp |
| 1999 | 100.0% | CN¥113.38 Million | CN¥0.00 | CN¥241.42 Million | ▲ +0.0 pp |
| 1998 | 100.0% | CN¥93.87 Million | CN¥0.00 | CN¥213.35 Million | — |